Salute e Benessere

Teledyne Photometrics announces new sCMOS camera for scientific imaging – 400…

New Kinetix sCMOS platform delivers an unmatched combination of speed, sensitivity, and field of view for scientific imaging Kinetix sCMOS camera which delivers an unmatched combination of speed, sensitivity, field of view, and resolution. The Kinetix is an all-new camera platform that builds on the success of the industry-defining Prime 95B and Prime BSI back-illuminated sCMOS cameras and redefines expectations of sCMOS camera speeds.Designed for the most demanding and...

Oxford Immunotec Schedules Third Quarter 2019 Earnings Release and Conference…

To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 7098484, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com . The replay will be available on the Company's website for approximately 60 days...

ICHOM Launch Healthcare Futures Podcast to Help Transform the Future of…

ICHOM has created a series of interviews by CEO and President, DrNeil Baconwith key leaders who are influencing the future of healthcare across the world. The podcasts are aimed at all those who work to change healthcare including patients, clinicians, leaders, executives, entrepreneurs or ground-breaking innovators. There is a global need to share experience, innovation and future possibilities for transforming healthcare. Healthcare Futures provides insights and ideas from the...

Rainwater Charitable Foundation Announces Inaugural Winners As Part of World's…

Launched in November 2018, the Rainwater Prize Program encourages and rewards scientific progress toward new treatments – and eventual cures – for neurodegenerative diseases related to the accumulation of tau protein in the brain. The Rainwater Prize Program fast-tracks scientific progress by encouraging additional research into neurodegenerative diseases, attracting new researchers to the tauopathy field, and recognizing scientific achievements that lead to new, effective treatments.…

Growing Awareness of CBD's Multifaceted Nature Eases Pressure from Regulators

FinancialBuzz.com News Commentary Newleaf Brands Inc. (OTC: NLBIF) (CSE: NLB) is also listed on the Canadian Securities Exchange under the ticker (CSE: NLB). Earlier last week, the Company's wholly owned subsidiary We Are Kured, LLC ("Kured") announced that, "it has successfully manufactured and fulfilled its first large white label 510 thread refill cartridge order for Indiana based distribution company, Must Haves, LLC ("Must Haves"). Must Haves is a well-established…

BerGenBio Receives FDA Approval of Fast Track Designation for Bemcentinib

Richard Godfrey, Chief Executive Officer of BerGenBio, commented: "We are thrilled that bemcentinib has been granted Fast Track Designation. Not only does this make us eligible for accelerated approval and priority review, but it serves as an important validation of bemcentinib in this significant unmet medical need we are trying to address. Currently, bemcentinib is in expanded Phase II trials in the U.S. and Europe for the treatment of AML and the Company has recently announced positive…

Clinical Trials for Acute Myeloid Leukemia (AML) Drug Therapy Advancing With…

PALM BEACH, Florida, Oct. 22, 2019 /PRNewswire/ -- There is much research activity in the acute myeloid leukemia (AML) the sector. The American Cancer Society's (ACS) estimates for leukemia in the United States for 2019 predict that there will be 61,780 new cases of leukemia (all kinds) and 22,840 deaths from leukemia (all kinds) and about 21,450 new cases of acute myeloid leukemia and about 10,920 deaths from AML. Most will be in adults. Although it is classified as an orphan's disease, many…

BioGX Receives CE-IVD Mark For Enhanced Flu Assay

"The launch of an enhanced Flu test is a testament to our team's ability to listen and address customers' needs with speed. Customers asked for a Flu test with broader coverage of specimen types without compromising sensitivity, and our team delivered," said Shazi Iqbal, Ph.D., CEO of BioGX. "The launch of an enhanced Flu test is a testament to our team's ability to listen and address customers' needs with speed. Customers asked for a Flu test with broader coverage of specimen…

BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone…

22.10.2019 BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada Our company BBS-Bioactive Bone Substitutes Plc's patent application ” A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION CONTAINING POLYETHYLENE GLYCOL/GLYCEROL MATRIX AND CALCIUM SALT GRANULES ” has been accepted in Canada. The same European and Eurasian patent has been valid about three years. CEOIlkka Kangasniemi : ”This...

Radient Technologies Inc. and The Edlong Corporation Announce Strategic…

Radient Technologies Inc.(“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ), a global commercial manufacturer of high-quality cannabinoid-based ingredients, formulations and products, andThe Edlong Corporation(“Edlong”), a global manufacturer, marketer and provider of technology-driven natural flavor systems, ingredients and integrated solutions for the food and beverage industry, are pleased to announce they have entered into a Memorandum of Understanding (the “MOU”) to...

Mallinckrodt Announces Launch of 2020 Award in Support of Advancing ECP…

STAINES-UPON-THAMES, United Kingdom, Oct. 22 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, has announced that its 2020 Advancing Extracorporeal Photopheresis (ECP) Immunomodulation Investigator Award is open for entries. STAINES-UPON-THAMES,United Kingdom, Oct. 22 2019 /PRNewswire/ --Mallinckrodtplc (NYSE: MNK), a global biopharmaceutical company, has announced that its 2020 Advancing Extracorporeal Photopheresis (ECP) Immunomodulation...

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based on…

New analysis of larger dataset showed that aducanumab reduced clinical decline in patients with early Alzheimer's disease as measured by the pre-specified primary and secondary endpoints Based on discussions with the FDA, the Company plans to submit a Biologics License Application in early 2020Biogen aims to offer aducanumab to eligible patients previously enrolled in clinical studies The positive results of this new analysis were driven primarily by greater exposure to high dose...

Nordic Nanovector Launches a Private Placement of New Shares

THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company"), a biopharmaceutical company dedicated to extending…

Zealand Pharma expands its peptide platform with acquisition of Encycle…

Company announcement – No. 37 / 2019 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics The transaction strengthens the leadership of Zealand Pharma (NASDAQ: ZEAL) in peptide therapeutics and in targeting gastrointestinal diseases with the addition of a pre-clinical, orally-delivered macrocycle peptide (integrin alpha-4-beta-7 inhibitor). Zealand Pharma also gains access to a unique screening library of some 5,000 peptide...

Organ Transplant Immunosuppressant Drugs Market Worth $5.88 Billion by 2026:…

Read 110 page research report with ToC on "Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antibodies), by Transplant, by Distribution Channel, and Segment Forecasts, 2019 - 2026" at: https://www.grandviewresearch.com/industry-analysis/organ-transplant-immunosuppressant-drugs-market Read 110 page research report with ToC on "Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends…

Apollo Hospitals' Unique Initiative to Provide Best Treatment Plan for Cancer…

Apollo Hospitals Cancer Opinion Initiative works on the principle of providing the best treatment available. The initiative allows a patient to submit his medical records online, which are then assessed by the board of oncologists – comprising of some of the best oncologists in India – and the patient is subsequently provided the best treatment plan. And all this is done before the patient travels for treatment! Apollo's Cancer Opinion is a Machine Learning based system, which gives evidence…

HCmed introduces Pulmogine in the 2019 ERS Congress

The introduction of Pulmogine mesh nebulizer comes at a time in which inhalation treatment is being further explored to substitute other administration routes in old and new therapies. During the congress, it was emphasized that new biologic drugs are recommended over potentially harmful oral steroids to treat asthma. Dr. Eger (MD) said, "Asthma patients using high doses of oral steroids are at risk of serious adverse effects such as diabetes, osteoporosis and adrenal insufficiency."…

Transactions in relation to share buyback program

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on market abuse and Delegated Regulation (EU) no. 2016/1052 of March 8, 2016, jointly referred to as the Safe Harbor rules (company announcement no. 23 of May 1, 2019). The share buyback program was initiated in order to reduce the company's share capital and to cover obligations...

JSC “Grindeks” oxytocin inclusion in World Health Organization List of…

JSC “Grindeks” informs that World Health Organization (WHO) has included oxytocin solution for injection 10 IU/ml in the List of Prequalified Medicinal Products.“Grindeks” oxytocin in the List of Prequalified Medicinal Products was included after 2 years of purposeful work and inspections of manufacturing sites. For the final dosage form (FDF) oxytocin to be prequalified, “Grindeks” had to receive WHO conclusions that the FDF meets several eligibility criteria. Company had to prepare product...

Enesi Pharma to Participate at the World Vaccine Congress Europe from 29th-31st…

The World Vaccine Congress is the largest and most established vaccine meeting of its kind across the globe. It brings together experts and decision-makers across commercial and scientific issues in manufacturing, clinical trials, strategy, regulation, veterinary vaccines, immune profiling, AMR, respiratory, influenza, therapeutic and emerging disease vaccines. TheWorld Vaccine Congress is the largest and most established vaccine meeting of its kind across the globe. It brings together...

Sectra Wins Medical Imaging Contract at Grady Health System in the U.S.

In addition to Sectra PACS for diagnostic radiology, the multi-year contract signed in September includes Sectra Breast Imaging PACS for mammography workflow, orthopedic 2D and 3D pre-operative planning tools, business analytics and cross platform worklists for sharing images with other health systems. In addition to Sectra PACS for diagnostic radiology, the multi-year contract signed in September includes Sectra Breast Imaging PACS for mammography workflow, orthopedic 2D and 3D pre-operative...

Head-to-head Study Shows Oral Ferric Maltol (FERACCRU®) May Be an Alternative…

- Oral ferric maltol delivered a haemoglobin (Hb) responder rate at 12 weeks that was well within the 20% non-inferiority limit (p=0.023) compared to IV ferric carboxymaltose (FCM) ( 74% vs 83%, respectively),[1] but without the need for hospital-based administration - Oral ferric maltol may offer an alternative treatment option to IV iron even in patients who have failed or not tolerated current oral iron treatments[1] Iron deficiency anaemia can be a serious complication of IBD resulting...

1 (current)
2
3
4
5
6
7
8
9
10
»